Virus-like Particle (VLP) Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509248655

Publication Date:

September 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Virus-like Particle (VLP) Service company offer both VLP production services and various VLP products for multiple applications, such as delivery system, vaccine development, and membrane protein expression.
The global market for Virus-like Particle (VLP) Service was estimated to be worth US$ 683 million in 2023 and is forecast to a readjusted size of US$ 1234.2 million by 2030 with a CAGR of 8.9% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Virus-like Particle (VLP) Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Virus-like Particle (VLP) Service by region & country, by Type, and by Application.
The Virus-like Particle (VLP) Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virus-like Particle (VLP) Service.
Market Segmentation
By Company
Creative Biostructure
Creative Diagnostics
Creative Biolabs
Creative Biogene
Segment by Type:
E. coli
Yeast
Insect Cells
Others
Segment by Application
Drug Research
Drug Target Recognition
Vaccine Development
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Virus-like Particle (VLP) Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Virus-like Particle (VLP) Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Virus-like Particle (VLP) Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Virus-like Particle (VLP) Service Product Introduction
1.2 Global Virus-like Particle (VLP) Service Market Size Forecast
1.3 Virus-like Particle (VLP) Service Market Trends & Drivers
1.3.1 Virus-like Particle (VLP) Service Industry Trends
1.3.2 Virus-like Particle (VLP) Service Market Drivers & Opportunity
1.3.3 Virus-like Particle (VLP) Service Market Challenges
1.3.4 Virus-like Particle (VLP) Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Virus-like Particle (VLP) Service Players Revenue Ranking (2023)
2.2 Global Virus-like Particle (VLP) Service Revenue by Company (2019-2024)
2.3 Key Companies Virus-like Particle (VLP) Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Virus-like Particle (VLP) Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Virus-like Particle (VLP) Service
2.6 Virus-like Particle (VLP) Service Market Competitive Analysis
2.6.1 Virus-like Particle (VLP) Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Virus-like Particle (VLP) Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus-like Particle (VLP) Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 E. coli
3.1.2 Yeast
3.1.3 Insect Cells
3.1.4 Others
3.2 Global Virus-like Particle (VLP) Service Sales Value by Type
3.2.1 Global Virus-like Particle (VLP) Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Virus-like Particle (VLP) Service Sales Value, by Type (2019-2030)
3.2.3 Global Virus-like Particle (VLP) Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Research
4.1.2 Drug Target Recognition
4.1.3 Vaccine Development
4.1.4 Others
4.2 Global Virus-like Particle (VLP) Service Sales Value by Application
4.2.1 Global Virus-like Particle (VLP) Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Virus-like Particle (VLP) Service Sales Value, by Application (2019-2030)
4.2.3 Global Virus-like Particle (VLP) Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Virus-like Particle (VLP) Service Sales Value by Region
5.1.1 Global Virus-like Particle (VLP) Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Virus-like Particle (VLP) Service Sales Value by Region (2019-2024)
5.1.3 Global Virus-like Particle (VLP) Service Sales Value by Region (2025-2030)
5.1.4 Global Virus-like Particle (VLP) Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Virus-like Particle (VLP) Service Sales Value, 2019-2030
5.2.2 North America Virus-like Particle (VLP) Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Virus-like Particle (VLP) Service Sales Value, 2019-2030
5.3.2 Europe Virus-like Particle (VLP) Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Virus-like Particle (VLP) Service Sales Value, 2019-2030
5.4.2 Asia Pacific Virus-like Particle (VLP) Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Virus-like Particle (VLP) Service Sales Value, 2019-2030
5.5.2 South America Virus-like Particle (VLP) Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Virus-like Particle (VLP) Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Virus-like Particle (VLP) Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Virus-like Particle (VLP) Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Virus-like Particle (VLP) Service Sales Value
6.3 United States
6.3.1 United States Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.3.2 United States Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.4.2 Europe Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.5.2 China Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.6.2 Japan Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.7.2 South Korea Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.8.2 Southeast Asia Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Virus-like Particle (VLP) Service Sales Value, 2019-2030
6.9.2 India Virus-like Particle (VLP) Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Virus-like Particle (VLP) Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Creative Biostructure
7.1.1 Creative Biostructure Profile
7.1.2 Creative Biostructure Main Business
7.1.3 Creative Biostructure Virus-like Particle (VLP) Service Products, Services and Solutions
7.1.4 Creative Biostructure Virus-like Particle (VLP) Service Revenue (US$ Million) & (2019-2024)
7.1.5 Creative Biostructure Recent Developments
7.2 Creative Diagnostics
7.2.1 Creative Diagnostics Profile
7.2.2 Creative Diagnostics Main Business
7.2.3 Creative Diagnostics Virus-like Particle (VLP) Service Products, Services and Solutions
7.2.4 Creative Diagnostics Virus-like Particle (VLP) Service Revenue (US$ Million) & (2019-2024)
7.2.5 Creative Diagnostics Recent Developments
7.3 Creative Biolabs
7.3.1 Creative Biolabs Profile
7.3.2 Creative Biolabs Main Business
7.3.3 Creative Biolabs Virus-like Particle (VLP) Service Products, Services and Solutions
7.3.4 Creative Biolabs Virus-like Particle (VLP) Service Revenue (US$ Million) & (2019-2024)
7.3.5 Creative Biogene Recent Developments
7.4 Creative Biogene
7.4.1 Creative Biogene Profile
7.4.2 Creative Biogene Main Business
7.4.3 Creative Biogene Virus-like Particle (VLP) Service Products, Services and Solutions
7.4.4 Creative Biogene Virus-like Particle (VLP) Service Revenue (US$ Million) & (2019-2024)
7.4.5 Creative Biogene Recent Developments
8 Industry Chain Analysis
8.1 Virus-like Particle (VLP) Service Industrial Chain
8.2 Virus-like Particle (VLP) Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Virus-like Particle (VLP) Service Sales Model
8.5.2 Sales Channel
8.5.3 Virus-like Particle (VLP) Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Creative Biostructure
Creative Diagnostics
Creative Biolabs
Creative Biogene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂